Bie ZX,Feng L ZX .2018 .Single-center clinical trial of first-line afatinib regimen versus cisplatin combined with pemetrexed regimen in the treatment of advanced non-small cell lung adenocarcinoma with EGFR mutation. Chin. J. Cancer Prevent, 25(10) : 740-745.
Castellanos E,Feld E,Horn L E .2017 .Driven by mutations: The predictive value of mutation subtype in egfr-mutated non-small cell lung cancer. J. Thorac. Oncol., 12(4) : 612-623.
Chen HR,Tian HQ,Chen ZM,Huang XW,Zheng XT,Chen XZ,Lin LZ .2018 .Effectiveness and safety of Kangai injection combined with single-agent chemotherapy in the treatment of elderly advanced non-small cell lung cancer. J. Pract. Med, 34(2) : 316-319.
Dal Bello MG,Filiberti RA,Alama A,Orengo AM,Mussap M,Coco S,Vanni I,Boccardo S,Rijavec E,Genova C,Biello F,Barletta G,Rossi G,Tagliamento M,Magginoi C,Grossi F C .2019 .The role of cea, cyfra21-1 and nse in monitoring tumor response to nivolumab in advanced non-small cell lung cancer (nsclc) patients. J. Transl. Med, 17(1) : 74.
Fang YJ,Pan JL,Lu HF,Jiang YP,Li SL,Hong GB .2019 .Early evaluate the feasibility and reproducibility of sorafenib targeted therapy for hepatocellular carcinoma by volume measurement approach. Chin. J. Radiology, 53(2) : 133-137.
Feng W,Chen X,Guan SX,Zhang L,Huang M,Wang XD .2018 .Correlation between MAPK1 gene polymorphism and gefitinib hepatotoxicity in patients with EGFR-sensitive non-small cell lung cancer. Acta Pharm, 53(5) : 760-764.
Guo G,Li H,Guo Q,Li GF .2016 .The effect of gefitinib on immune function of patients with nonsmall cell lung cancer. Chin. J. Clin. Pharmacol, 32(6) : 505-507.
He WL,Zhang H,Wang YF,Zhou YB,Luo YF,Cui YM,Jiang N,Jiang WT,Wang H,Xu D,Li SH,Wang Z,Chen YS,Sun Y,Zhang Y,Tseng HR,Zou XN,Wang LT,Ke ZF .2018 .Cthrc1 induces non-small cell lung cancer (nsclc) invasion through upregulating mmp-7/mmp-9. , 18(1) : 400.
Leonetti A,Sharma S,Minari R,Perego P,Giovannetti E,Tiseo M .2019 .Resistance mechanisms to osimertinib in egfr-mutated non-small cell lung cancer. Brit. J. Cancer, 121(9) : 725-737.
Lin GH,Lin LZ,Zhang Y,Pei WY,Zeng JC,Zhao WX .2019 .Influence of fire needle stimulation at Sihua acupoints on performance status and Th1/Th2 balance in the patients with advanced non-small cell lung cancer after chemotherapy. Acupuncture Res., 44(2) : 136-139.
Liu T,Xiong Q,Hu Y .2018 .Clinical observation of albumin-bound paclitaxel combined with tegafur in the first-line treatment of elderly patients with advanced pancreatic cancer. J. Mod. Oncol., 26(5) : 722-725.
Peng M,Weng YM,Chen L,Song QB .2018 .Metaanalysis of the efficacy and safety of EGFR-TKI combined chemotherapy versus EGFR-TKI alone in the treatment of EGFR-mutated advanced non-small cell lung cancer. China Cancer, 27(11) : 874-880.
Rafei H,El-Bahesh E,Finianos A,Nassereddine S,Tabbara I .2017 .Immune-based Therapies for Nonsmall Cell Lung Cancer. Anticancer Res., 37(2) : 377-387.
Tian CY,Li FY,Yang J,Zhao Y,Chu GW Y .2018 .Clinical efficacy of gefitinib combined with gemcitabine and cisplatin chemotherapy in treatment of patients with advanced non-small cell lung cancer and its effect on serum tumor markers. Med. J. Chin. People's Liberation Army, 30(4) : 25-28.
Pi Wang J,C Wang J .2018 .Comparison of the efficacy of osimertinib versus pemetrexed combined with platinum-based chemotherapy on patients with EGFR T790M positive non-small cell lung cancer. J. Evidbased Med, 18(1) : 36-39.
Wang XL,Yuan F,Wu XN,Xu MQ .2013 .Characteristics and clinical significance of immune cells in tumor microenvironment of non-small cell lung cancer. J. Clin. Pulm. Med, 18(2) : 282-288.
Wang XM,Chen J,Yao JQ,Guo RH .2018 .The efficacy of gefitinib combined with pericardial perfusion in the treatment of advanced non-small cell lung cancer. Chin. J. Lung Cancer, 21(1) : 37-42.
Wu SG,Shih JY .2018 .Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer. Mol. Cancer, 17(1) : 38.
Zeng XQ,Tan M,Ren YF M .2018 .Effects of staged cognitive behavioral intervention on negative emotion and quality of life in patients with non-small cell lung cancer chemotherapy. Chin. J. Clin. Oncol. Rehabil, 25(4) : 484-487.
Zhang D,Yang G,Zhang SG .2015 .The effect of gefitinib on immune function of patients with lung squamous cell carcinoma and its short-term clinical efficacy. Anhui Med, 19(7) : 1367-1370.
Zhang YB,Sun L,Wang JP,Song LJ,Xia JH .2018 .Expression and significance of CHCHD2 and HIF-1α in non-small cell lung cancer. Chin. J. Clin. Exp, 34(11) : 1230-1234.
Zhao S,Qiao WL,Qiu ZX,Li L,Li WM .2018 .Pharmacoeconomics systematic review of gefitinib in the treatment of advanced non-small cell lung cancer. West Chin. Med, 33(1) : 76-83.
Zhou F,Du J,Wang JJ .2017 .Albendazole inhibits hif-1α-dependent glycolysis and vegf expression in non-small cell lung cancer cells. Mol. Cell, 428(1-2) : 171-178.